Page last updated: 2024-09-05

regadenoson and Headache

regadenoson has been researched along with Headache in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Duvall, WL; Elsadany, M; McMahon, SR; Mehla, S	1
Alam, M; Ananthasubramaniam, K; Boedeker, S; Brooks, K; Iyer, H; Khandelwal, A; Nguyen, P; Saad, H; Shaikh, K; Wang, DD	1
Belardinelli, L; Frohna, P; Gordi, T; Lieu, H; Sun, HL; Wolff, A	1

Trials

1 trial(s) available for regadenoson and Headache

Article	Year
A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers. Clinical pharmacokinetics, 2006, Volume: 45, Issue:12 Topics: Adenosine A2 Receptor Agonists; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Headache; Heart Rate; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nausea; Purines; Pyrazoles; Vasodilator Agents; Vomiting	2006

Article

Year

A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.

Clinical pharmacokinetics, 2006, Volume: 45, Issue:12

Topics: Adenosine A2 Receptor Agonists; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Headache; Heart Rate; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nausea; Purines; Pyrazoles; Vasodilator Agents; Vomiting

2006

Other Studies

2 other study(ies) available for regadenoson and Headache

Article	Year
Hemiplegic migraine episode triggered by regadenoson. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:6 Topics: Adenosine A2 Receptor Agonists; Exercise Test; Headache; Hemiplegia; Humans; Migraine Disorders; Myocardial Perfusion Imaging; Seizures; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents	2022
Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study. The international journal of cardiovascular imaging, 2014, Volume: 30, Issue:3 Topics: Adenosine A2 Receptor Agonists; Anti-Arrhythmia Agents; Atropine; Coronary Angiography; Coronary Artery Disease; Dyspnea; Echocardiography, Stress; Feasibility Studies; Female; Headache; Humans; Male; Middle Aged; Patient Satisfaction; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires	2014

Article

Year

Hemiplegic migraine episode triggered by regadenoson.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022, Volume: 29, Issue:6

Topics: Adenosine A2 Receptor Agonists; Exercise Test; Headache; Hemiplegia; Humans; Migraine Disorders; Myocardial Perfusion Imaging; Seizures; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

2022

Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress echocardiography for the diagnosis of coronary artery disease: an angiographic correlative study.

The international journal of cardiovascular imaging, 2014, Volume: 30, Issue:3

Topics: Adenosine A2 Receptor Agonists; Anti-Arrhythmia Agents; Atropine; Coronary Angiography; Coronary Artery Disease; Dyspnea; Echocardiography, Stress; Feasibility Studies; Female; Headache; Humans; Male; Middle Aged; Patient Satisfaction; Predictive Value of Tests; Prospective Studies; Purines; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires

2014